Vivos' cost-cutting initiatives also led to a $1 million or 27% year-over-year reduction in operating loss, versus the third quarter of 2023. For the nine months ended September 30, 2024 operating ...
Call Scheduled for Thursday, November 14, 2024 at 5:00 pm ETLITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical ...
Do you suffer from sleep apnea and long for a peaceful night’s sleep and solution to your snoring? Holy Cross Medical Group pulmonologist Ronald Scott, M.D. will speak about Inspire®, an FDA-approved ...
Sleep apnea at age 50 and over is linked to a higher risk of dementia- especially among women. The findings offer new insight into the role of sleep apnea on long-term cognitive health. The ...
I’ve been diagnosed with sleep apnea. I have tried to use a continuous positive airway pressure device for the past six months but can’t tolerate it. Are ...